Illustrative — not actual patient/client data. Synthetic example for demonstration only.
Prepared for
Acme Manufacturing
Self-Funded Employer · July 1 – September 30, 2026
Episode Summary
45
Episodes Routed
Unique members placed
87%
Completion Rate
39 of 45 completed treatment
4.2%
30-Day Readmission Rate
2 of 39 completed episodes
Episodes by Condition Category
| Category |
Routed |
Completed |
Rate |
Avg Duration |
| Substance Use Disorder |
18 |
15 |
83% |
32 days |
| Major Depressive Disorder |
12 |
11 |
92% |
28 days |
| Anxiety Disorders |
8 |
7 |
88% |
21 days |
| Eating Disorders |
4 |
4 |
100% |
45 days |
| Co-occurring (MH + SUD) |
3 |
2 |
67% |
38 days |
Navigator Accountability
Touchpoint Completion
94%
Scheduled check-ins completed on time
Time-to-Placement
<48 hrs
Median from referral to confirmed admission
Post-Discharge Follow-Up
91%
7-day post-discharge contact rate
Member Satisfaction
4.6 / 5.0
Post-episode survey (n=34)
Clinical Outcome Scores
PHQ-9 Average Improvement
-6.8 pts
Intake mean: 17.2 → Discharge mean: 10.4
Clinically meaningful improvement
AUDIT-C Average Improvement
-4.1 pts
Intake mean: 8.3 → Discharge mean: 4.2
Below clinical threshold at discharge
GAD-7 Average Improvement
-5.3 pts
Intake mean: 14.1 → Discharge mean: 8.8
Moderate to mild reduction
Functional Status (WHODAS 2.0)
-11.2 pts
Intake mean: 38.4 → Discharge mean: 27.2
Improved functional capacity
Readmission Warranty Status
On Track
30-Day Readmission Warranty
2 readmissions within warranty period (4.2%). Warranty covers re-treatment at no additional episode cost. Both members re-entered care within 14 days of initial discharge. One SUD, one co-occurring.
Equity Snapshot
| Dimension |
Metric |
Value |
Benchmark |
| Gender |
Female routing rate |
53% |
Population: 51% |
| Age |
18-25 completion rate |
81% |
Overall: 87% |
| Geography |
Rural member placement <72 hrs |
88% |
Urban: 96% |
| Race/Ethnicity |
Non-white satisfaction score |
4.5 / 5.0 |
White: 4.7 / 5.0 |
Summary
Curated routed 45 episodes during Q3 2026, with an 87% completion rate and a 30-day readmission rate of 4.2%. Navigator accountability remained strong: 94% touchpoint completion and a median time-to-placement under 48 hours. Clinical outcome measures showed meaningful improvement across PHQ-9, AUDIT-C, GAD-7, and WHODAS 2.0 instruments. Two members re-entered care under the readmission warranty. The equity snapshot identified a completion rate gap for members aged 18-25 and a placement speed gap for rural members. Both are under review for Q4 protocol adjustments.
42 CFR Part 2 — Re-Disclosure Notice
This report may contain information protected by 42 CFR Part 2, governing the confidentiality of substance use disorder (SUD) patient records. This information has been disclosed from records protected by federal confidentiality rules. Federal regulations (42 CFR Part 2) prohibit any further disclosure of this information unless further disclosure is expressly permitted by written consent of the individual to whom it pertains, or as otherwise permitted by 42 CFR Part 2. A general authorization for the release of medical or other information is not sufficient for this purpose. The federal rules restrict any use of this information to investigate or prosecute with regard to a crime any patient with a substance use disorder.
Confidentiality
This report is prepared exclusively for the named employer. All clinical data is aggregated; no individual-level protected health information is disclosed. Curated operates as an episode-based behavioral health network under Cadence, LLC. Navigator assignments, program placements, and outcome measurements are proprietary to the Curated network.
← Back to Curated